Valeant CEO subpoenaed to testify before U.S. Senate panel

WASHINGTON, March 28 (Reuters) - The chief executive of

Valeant Pharmaceuticals International Inc, which is

under scrutiny for dramatically hiking the price of older drugs,

has been summoned to...

Read more